Ls 2x Salesforc (CRME)

Ls 2x Salesforc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:CRME

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
24/04/2023	15:47	UK Regulatory	Leverage Shares PLC Issuer Call Redemption Confirmation	LSE:CRME	Ls 2x Salesforc
21/12/2009	22:05	PR Newswire (US)	Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase Plans	LSE:CRME
17/12/2009	23:00	PR Newswire (US)	Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study	LSE:CRME
09/11/2009	13:40	PR Newswire (US)	Cardiome Reports Third Quarter Results	LSE:CRME
06/11/2009	23:00	PR Newswire (US)	Cardiome to Release Third Quarter Results	LSE:CRME
02/11/2009	19:35	PR Newswire (US)	Cardiome To Present At Oppenheimer Healthcare Conference	LSE:CRME
28/10/2009	20:58	PR Newswire (US)	Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial	LSE:CRME
17/10/2009	01:54	PR Newswire (US)	Cardiome Pharma Corp. Announces Final Results of Tender Offer	LSE:CRME
14/10/2009	11:00	PR Newswire (US)	Cardiome Pharma Corp. Announces Preliminary Results of Tender Offer	LSE:CRME
01/09/2009	19:57	PR Newswire (US)	Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender Offer	LSE:CRME
28/08/2009	18:30	PR Newswire (US)	Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of	LSE:CRME
25/08/2009	22:11	PR Newswire (US)	Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares	LSE:CRME
11/08/2009	12:45	PR Newswire (US)	Cardiome Reports Second Quarter Results	LSE:CRME
11/08/2009	00:45	PR Newswire (US)	Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement	LSE:CRME
10/08/2009	21:35	PR Newswire (US)	Cardiome to Hold Conference Call	LSE:CRME
03/08/2009	22:16	PR Newswire (US)	Cardiome Announces Management Transition	LSE:CRME
28/07/2009	16:45	PR Newswire (US)	Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.	LSE:CRME
19/05/2009	13:30	PR Newswire (US)	Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective	LSE:CRME
15/05/2009	21:05	PR Newswire (US)	Cardiome Reports First Quarter Results	LSE:CRME
08/04/2009	23:13	PR Newswire (US)	Cardiome to Hold Conference Call	LSE:CRME
28/11/2008	22:31	PR Newswire (US)	Cardiome Discloses Chairman And CEO's Involuntary Share Sale	LSE:CRME
14/11/2008	23:40	PR Newswire (US)	Cardiome Reports Third Quarter Results	LSE:CRME
24/10/2008	03:40	PR Newswire (US)	Cardiome Announces Filing Of Shelf Registration Statement	LSE:CRME
09/10/2008	17:20	PR Newswire (US)	Cardiome Provides Regulatory Update	LSE:CRME
12/08/2008	21:05	PR Newswire (US)	Cardiome Reports Second Quarter Results	LSE:CRME
11/08/2008	21:30	PR Newswire (US)	Cardiome to Release Second Quarter Results and Hold Conference Call	LSE:CRME
11/08/2008	14:18	PR Newswire (US)	Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)	LSE:CRME
23/07/2008	19:10	PR Newswire (US)	Cardiome Announces Preferred Share Financing	LSE:CRME
14/07/2008	13:25	PR Newswire (US)	Cardiome Announces Positive Phase 2b Results For Oral Vernakalant	LSE:CRME
13/07/2008	17:00	PR Newswire (US)	Cardiome To Hold Conference Call	LSE:CRME